In the HM cohort, LUMA hypomethylation was associated with diabetes (p = 0.03) and had a nearly significant association with advanced age (p = 0.08), hyperlipidemia (p = 0.06) and CAD (p = 0.08). Here, TMEM43 is linked to coronary artery disorder.